Exchange: NASDAQ·Updated 07:31 PM EDT
CGEM logo

CGEM Cullinan Oncology Inc

$22.09
$0.07
(0.32%)
Today
Closed $22.09
$0.3874
(1.75%)
After Hours
EarningsNov 5
Mkt Cap$1.42B
Vol562,486.00

About CGEM

Cullinan Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the developing of oncology and immuno-oncology therapies. Its pipeline includes CLN-978, CLN-619, Zipalertinib CLN-081/TAS6417, CLN-049, and CLN-617. The company was founded by Patrick A. Baeuerle on September 15, 2016 and is headquartered in Cambridge, MA.
32

Bearish Sentiment

How do you feel about CGEM?

Advertisement|Remove ads.